Clinical Trials Directory

Trials / Completed

CompletedNCT03196648

Randomized Trial of a Gum Health Formulation

A Randomized Trial Evaluating the Efficacy of a Gum Health Formulation on Gingival Inflammation, Oral Malodor and Tooth Whitening

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Glo Science, Inc. · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety and efficacy of a newly formulated foaming gel product on gingivitis and/or moderate periodontitis when used with or without the GLO Science accelerating device (GLO Device), compared to standard tooth brushing with antioxidant whitening toothpaste with or without flossing (split mouth design for control group). This is a 60-day randomized single blinded parallel group study. After 42 days, all use of interventional products were discontinued, and the participants returned to the clinical center at day 60 for final measurements. The primary outcomes assessed in this study were the differences in gingival index (GI) and bleeding on probing (BOP) from baseline to 42 \& 60 days. The secondary outcomes are tooth whitening, oral malodor, pocket depth and plaque amount. It is hypothesized that participants using the gingival health product with the GLO Device will experience greater reductions in GI \& BOP measurements than the control group, as well as participants using the gingival health product on a toothbrush alone.

Conditions

Interventions

TypeNameDescription
OTHERGingival health formulation in an accelerating deviceThe intervention is a gingival health formulation for soft tissue maintenance, oral malodor and gentle teeth whitening to be used with the GLO Science Device
OTHERGingival health formulation on a toothbrushThe intervention is a gingival health formulation for soft tissue maintenance, oral malodor and gentle teeth whitening to be used on a toothbrush together with toothpaste.
OTHEROTC fluoride toothpasteOTC anti-cavity toothpaste containing fluoride and sodium monofluorophosphate.

Timeline

Start date
2015-05-01
Primary completion
2016-11-30
Completion
2016-11-30
First posted
2017-06-23
Last updated
2017-06-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03196648. Inclusion in this directory is not an endorsement.